- Filed
- Aug 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 5, 2025 | 15.01M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 14.52M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 14.45M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 14.31M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 14.27M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $1.85M |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $358K |
| Capex | Q2 2025 · Jun 30, 2025 | $902K |
| Capex | Q2 2025 · Jun 30, 2024 | $306K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $14.52M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $11.73M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $163.11M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $168.6M |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $2.98M |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $2.98M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $12.28M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $12.32M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $173.17M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $168.51M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $168.7M |
| Stockholders Equity restated | Q2 2025 · Jun 30, 2024 | $179.78M |
| Stockholders Equity restated | Q2 2025 · Mar 31, 2024 | $182.69M |
| Stockholders Equity restated | Q2 2025 · Dec 31, 2023 | $183.97M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $50.18M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $52.98M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $216.98M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $225.74M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $90.26M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $90.27M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $390.15M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $394.43M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.17 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.20 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$0.29 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$0.42 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.17 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.20 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$0.29 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$0.42 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $18.08M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $37.54M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $18.88M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $38.27M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $8.11M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $16.36M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $8.21M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $18.89M |
| Net Income | Q2 2025 · Jun 30, 2025 | $2.58M |
| Net Income | Q2 2025 · Jun 30, 2025 | $3.04M |
| Net Income restated | Q2 2025 · Jun 30, 2024 | −$4.39M |
| Net Income restated | Q2 2025 · Jun 30, 2024 | −$6.24M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $3.63M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $11.79M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | −$2.15M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | −$2.74M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $41.27M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $80.78M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $43.34M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $85.1M |
| Revenue | Q2 2025 · Jun 30, 2025 | $85.73M |
| Revenue | Q2 2025 · Jun 30, 2025 | $172.94M |
| Revenue restated | Q2 2025 · Jun 30, 2024 | $85.6M |
| Revenue restated | Q2 2025 · Jun 30, 2024 | $169.72M |